FindTrial
Sign In

The molecular biological analysis of cell line and Xenograft line establishment and drug susceptibility of gastrointestinal stromal tumors

The molecular biological analysis of cell line and Xenograft line establishment and drug susceptibility of gastrointestinal stromal tumors - The molecular biological analysis of cell line and Xenograft line establishment and drug susceptibility of gastrointestinal stromal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000015819
Enrollment
70
Registered
2014-12-02
Start date
2014-12-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal stromal tumors (GIST)

Interventions

None listed

Sponsors

Department of Surgery, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing surgery with gastrointestinal stromal tumors (GIST)

Exclusion criteria

Exclusion criteria: 1. PS 3 or 4 2. Infancy 3. Apparent tumor residual 4. Patients with congenital or acquired coagulation defect

Design outcomes

Primary

MeasureTime frame
To establish cell line and Xenograft line from surgical specimen in order to survey clinical condition or drug resistance of gastrointestinal stromal tumors—

Countries

Japan

Contacts

Public ContactKazumasa Fukuda

Keio University School of Medicine Department of Surgery

fukudak@z6.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026